Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Completed · Phase 1
Conditions studied: Cholangiocarcinoma, Liver Cancer, Adenocarcinoma
In brief
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical (cross-firing) technique. A second purpose is to establish a safe dose for such therapy. Finally, the efficacy of radiosurgical ablation of liver tumors, in terms of radiographic response, will be measured.
Key facts
- Study ID
- NCT00230347
- Run by
- Stanford University
- People needed
- 20
- Starts
- 2003-10-01
- Expected to finish
- 2007-02-01
- Last updated by the study team
- 2010-04-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.